Partner
2021
RA Capital (2020 - 2021)
Boston, MA | Principal, Tools and Diagnostics
Farcast Biosciences / Mitra Biotech (2015 - 2020)
Woburn, MA | Head of Strategy, Chief Commercial Officer
RA Capital (2015)
Boston, MA | Entrepreneur in Residence
Becton Dickinson (2006 - 2014)
Franklin Lakes, NJ | VP
Serologicals / Upstate Biotechnology (2000 - 2006)
Charlottesville, VA | VP
Pratt & Whitney (1996 - 1998)
Hartford, CT | Manufacturing Engineer
University of Virginia (2000)
MBA | Darden School
Boston University (1995)
BS | Mechanical Engineering
Parker is a Partner of the Sands Capital Life Sciences Pulse Strategy and joined Sands Capital in 2021. Parker has 20 years of operational experience with life science tools, diagnostics and device companies in a range of commercial, development and general management roles. In those roles, he’s been accountable for revenue ranging from launch up to $70M annually, he’s led acquisitions and integrations and he’s designed and executed multiple clinical trials. He has been an advisor, investor and board member for private life science companies since 2015. Parker has a degree in Mechanical Engineering from Boston University and an MBA from the Darden School at the University of Virginia.
Sands Capital
1000 Wilson Boulevard, Suite 3000
Arlington, Virginia 22209 USA
1.703.562.4000
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines analytical rigor and creative thinking to identify high-quality growth businesses that are creating the future. Through an integrated investment platform spanning venture capital, growth equity and public equity, we provide growth capital solutions to institutions and fund sponsors in more than 40 countries.
An independent, staff-owned firm founded in 1992 and headquartered in the Washington, D.C. area with offices in London and Singapore, Sands Capital managed more than $43.8 billion in client assets as of December 31, 2022.
© 2023 Sands Capital. All Rights Reserved.
For institutional and professional investors only.
Investment advisory fees are described in Part II of the adviser’s Form ADV.